Telomere-related DNA damage response pathways in cancer therapy: prospective targets
Frontiers in Pharmacology · 07.06.2024 · 15
DOI: 10.3389/fphar.2024.1379166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.06.2024. Verfasst von Liting Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Maintaining the structural integrity of genomic chromosomal DNA is an essential role of cellular life and requires two important biological mechanisms: the DNA damage response (DDR) mechanism and telomere protection mechanism at chromosome ends. Because abnormalities in telomeres and cellular DDR regulation are strongly associated with human aging and cancer, there is a reciprocal regulation of telomeres and cellular DDR. Moreover, several drug treatments for DDR are currently available. This paper reviews the progress in research on the interaction between telomeres and cellular DNA damage repair pathways. The research on the crosstalk between telomere damage and DDR is important for improving the efficacy of tumor treatment. However, further studies are required to confirm this hypothesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
- Department of Urology, The First Hospital of Jilin University, Changchun, Jilin, China.
Zitieren
APA
Gu, L., Liu, M., Zhang, Y., Zhou, H., Wang, Y., & Xu, Z. X. (2024). Telomere-related DNA damage response pathways in cancer therapy: prospective targets. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1379166
Vancouver
Gu L, Liu M, Zhang Y, Zhou H, Wang Y, Xu ZX. Telomere-related DNA damage response pathways in cancer therapy: prospective targets. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1379166
BibTeX
@article{Gu2024,
author = {Gu, Liting and Liu, Mingdi and Zhang, Yuning and Zhou, Honglan and Wang, Yishu and Xu, Zhi-Xiang},
title = {Telomere-related DNA damage response pathways in cancer therapy: prospective targets},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1379166}
}
EUVIMED